Status:

RECRUITING

Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant Formula

Lead Sponsor:

United Pharmaceuticals

Collaborating Sponsors:

Axiodis CRO

Conditions:

Functional Gastrointestinal Disorders

Eligibility:

All Genders

Up to 4 years

Phase:

NA

Brief Summary

This study aims to assess the evolution of functional gastrointestinal disorders (FGIDs) in infants fed with a new infant formula, using the Gastrointestinal (GI) and gastroesophageal reflux (GER) (GI...

Detailed Description

The study comprises a first period of 30 days followed by an optional intervention period of 90 days.

Eligibility Criteria

Inclusion

  • Infants presenting with at least one of the FGIDs below, defined based on adapted Rome IV criteria as follows:
  • 1 Regurgitations: 1.2 Colic: 1.3 Constipation:
  • Infants born at 35 weeks or more of gestational age
  • Infants up to 4 months of age

Exclusion

  • Exclusively or partially breastfed infants (i.e. \> 2 breast feeds per day) with maternal willingness to continue breastfeeding
  • Diversified infants or whose parents intend to start diversification within the first 2 weeks of the study
  • Use of antibiotics at inclusion visit (V0) and within 7 days before the inclusion visit (V0)
  • The willingness to take additional pre-, probiotics or thickening agents during the study
  • Known allergy/intolerance to any of the product ingredients or suspected allergy to cow's milk requiring an eviction diet
  • Infants presenting with any other situation including the participation in another clinical trial, which, according to the investigator, may interfere with the study participation, or lead to a particular risk for the patient
  • (non exhaustive list)

Key Trial Info

Start Date :

October 21 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2026

Estimated Enrollment :

139 Patients enrolled

Trial Details

Trial ID

NCT06488274

Start Date

October 21 2024

End Date

April 1 2026

Last Update

January 6 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Site 02

Nice, France

2

Site 04

Paris, France

3

Site 03

Toulon, France

4

Site 01

Vincennes, France